Wells Fargo & Company Innoviva, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Innoviva, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 24,902 shares of INVA stock, worth $498,040. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,902

Previous 21,524 15.69%

Holding current value

$498,040

Previous $328,000 24.39%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$14.4 - $16.4 $48,643 - $55,399	3,378 Added 15.69%	24,902 $408,000
Q1 2024 May 10, 2024	BUY	$14.56 - $16.78 $24,737 - $28,509	1,699 Added 8.57%	21,524 $328,000
Q4 2023 Feb 09, 2024	BUY	$12.32 - $16.27 $46,384 - $61,256	3,765 Added 23.44%	19,825 $317,000
Q3 2023 Nov 13, 2023	SELL	$12.37 - $13.89 $154,761 - $173,777	-12,511 Reduced 43.79%	16,060 $208,000
Q2 2023 Aug 15, 2023	BUY	$11.39 - $13.72 $129,151 - $155,571	11,339 Added 65.8%	28,571 $363,000
Q1 2023 May 12, 2023	SELL	$10.73 - $13.6 $198,569 - $251,681	-18,506 Reduced 51.78%	17,232 $193,000
Q4 2022 Feb 13, 2023	SELL	$11.8 - $13.78 $17,829 - $20,821	-1,511 Reduced 4.06%	35,738 $473,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $357,506 - $468,669	30,793 Added 476.97%	37,249 $433,000
Q2 2022 Aug 12, 2022	SELL	$14.32 - $19.88 $1.77 Million - $2.46 Million	-123,939 Reduced 95.05%	6,456 $95,000
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $43,799 - $57,631	-2,846 Reduced 2.14%	130,395 $2.52 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $2.36 Million - $2.77 Million	-148,062 Reduced 52.63%	133,241 $2.3 Million
Q3 2021 Nov 15, 2021	SELL	$13.06 - $17.24 $916,067 - $1.21 Million	-70,143 Reduced 19.96%	281,303 $4.7 Million
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $811,576 - $989,484	70,880 Added 25.26%	351,446 $4.71 Million
Q1 2021 May 13, 2021	BUY	$11.06 - $12.87 $377,953 - $439,806	34,173 Added 13.87%	280,566 $3.35 Million
Q4 2020 Feb 09, 2021	BUY	$9.33 - $12.48 $9,152 - $12,242	981 Added 0.4%	246,393 $3.05 Million
Q3 2020 Nov 05, 2020	BUY	$10.33 - $14.49 $627,557 - $880,281	60,751 Added 32.9%	245,412 $2.56 Million
Q2 2020 Aug 13, 2020	BUY	$11.49 - $15.26 $265,499 - $352,612	23,107 Added 14.3%	184,661 $2.58 Million
Q1 2020 May 14, 2020	BUY	$8.11 - $15.23 $1.31 Million - $2.46 Million	161,554 New	161,554 $1.9 Million

Others Institutions Holding INVA

# of Institutions

222

Shares Held

78.9M

Call Options Held

20K

Put Options Held

5.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.39B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Innoviva, Inc. Transaction History